HomeNewsBusinessEconomyPercentage of patients requiring supplemental oxygen has risen in second wave: ICMR

Percentage of patients requiring supplemental oxygen has risen in second wave: ICMR

The ICMR compared data on hospitalised patients from September-November 2020 for the first wave, and March-April (so far) for the second wave. The presentation showed that the mean age of hospitalised patients has reduced only slightly in the second wave, to 48.9 years from 50.4 years.

April 19, 2021 / 17:10 IST
Story continues below Advertisement
A worker in Prayagraj filling oxygen cylinders, for use in a Covid-19 hospital facility. Photo: Sanjay Kanojia / AFP
A worker in Prayagraj filling oxygen cylinders, for use in a Covid-19 hospital facility. Photo: Sanjay Kanojia / AFP

The percentage of COVID-19 patients in the ‘second wave’ requiring supplemental oxygen support has increased compared to the ‘first wave’, while those requiring ventilator support has decreased, as per a presentation by the Indian Council of Medical Research (ICMR) on April 19. The presentation stated that the supply of oxygen needed to be ramped up.

The ICMR compared data on hospitalised patients from September-November 2020 for the first wave, and March-April (so far) for the second wave. The presentation, shared with journalists, showed that the mean age of hospitalised patients has reduced only slightly in the second wave, to 48.9 years from 50.4 years.

Story continues below Advertisement

The data showed that 54.5 per cent of all COVID-19 admissions in the second wave required supplemental oxygen and 27.8 required ventilator support, compared with 27.8 percent and 37.3 percent in the first wave.

The presentation was attended by senior government officials including Niti Aayog member VK Paul.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show